Please wait while the formulary information is being retrieved.
SUCRALFATE (SUCRALFATE)
- Duodenal ulcer
100 mg/mL oral suspension
- 10 milliliters (1 gram) by oral route 4 times per day on an empty stomach 1 hour before meals and at bedtime
100 mg/mL oral suspension
- 10 milliliters (1 gram) by oral route 4 times per day on an empty stomach 1 hour before meals and at bedtime
Duodenal ulcer
- 10 milliliters (1 gram) by oral route 4 times per day on an empty stomach 1 hour before meals and at bedtime
- 10 milliliters (1 gram) by oral route 4 times per day on an empty stomach 1 hour before meals and at bedtime for 4 weeks
- 10 milliliters (1 gram) by oral route 4 times per day on an empty stomach 1 hour before meals and at bedtime for 8 weeks
- 20 milliliters (2 gram) by oral route 2 times per day on an empty stomach on waking and at bedtime
- 20 milliliters (2 gram) by oral route 2 times per day on an empty stomach on waking and at bedtime for 4 weeks
- 20 milliliters (2 gram) by oral route 2 times per day on an empty stomach on waking and at bedtime for 8 weeks
- None
Contraindicated
- Adoxa
- Avidoxy
- Cuprimine
- deferasirox
- demeclocycline
- Depen Titratabs
- Doryx
- doxycycline calcium
- doxycycline hyclate
- doxycycline monohydrate
- Exjade
- Minocin
- minocycline
- Monodox
- Morgidox
- Oracea
- penicillamine
- Solodyn
- tetracycline
- Vibramycin
Severe
Moderate
- Armour Thyroid
- Avelox
- Avelox Abc Pack
- chloroquine phosphate
- Cipro
- Cipro Xr
- ciprofloxacin
- ciprofloxacin (mixture)
- Cytomel
- Digox
- digoxin
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- dolutegravir
- eltrombopag
- ethotoin
- hydroxychloroquine
- ketoconazole
- Lanoxin
- Lanoxin Pediatric
- Levaquin
- levofloxacin
- levothyroxine
- Levoxyl
- liothyronine
- liotrix
- moxifloxacin
- Nature-throid
- norfloxacin
- Noroxin
- Np Thyroid
- ofloxacin
- Peganone
- Phenytek
- phenytoin
- phenytoin sodium extended
- Plaquenil
- Promacta
- Synthroid
- thyroid (pork)
- Thyrolar-1
- Thyrolar-1/2
- Thyrolar-1/4
- Thyrolar-2
- Thyrolar-3
- Tirosint
- Tivicay
- Unithroid
- Westhroid
- Wp Thyroid
- None
Contraindicated
- Aluminum toxicity
- Chronic kidney disease stage 5 (failure) GFr<15 ml/min
Severe
Moderate
- Hyperglycemia
SUCRALFATE (SUCRALFATE)
- Duodenal ulcer
- None
- Constipation
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Angioedema
- Bronchospastic pulmonary disease
- Facial edema
- Gastrointestinal concretion
- Laryngismus
- Pharyngeal edema
- Pruritus of skin
- Respiration changes
- Skin rash
- Urticaria
Less Severe
- Back pain
- Diarrhea
- Dizziness
- Drowsy
- Dyspepsia
- Edema
- Flatulence
- Headache disorder
- Hyperglycemia
- Insomnia
- Nausea
- Vertigo
- Vomiting
- Xerostomia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Sucralfate
Safety and efficacy not established.
- 1 Day – 364 Days
- Safety and efficacy not established.
Sucralfate
- Severity Level:
B
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Sucralfate
Insuff data avail; excr. unlikely, less than 5% of drug absorbed systemically
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insuff data avail; excr. unlikely, less than 5% of drug absorbed systemically |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Sucralfate
Renal-Use causes small amounts of aluminum to be absorbed from the GI tract. In chronic renal failure, aluminum can accumulate to toxic levels. Use caution with CLCr < 30 mL/minute.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | N | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Duodenal ulcer | |
| K26 | Duodenal ulcer |
| K26.0 | Acute duodenal ulcer with hemorrhage |
| K26.1 | Acute duodenal ulcer with perforation |
| K26.2 | Acute duodenal ulcer with both hemorrhage and perforation |
| K26.3 | Acute duodenal ulcer without hemorrhage or perforation |
| K26.4 | Chronic or unspecified duodenal ulcer with hemorrhage |
| K26.5 | Chronic or unspecified duodenal ulcer with perforation |
| K26.6 | Chronic or unspecified duodenal ulcer with both hemorrhage and perforation |
| K26.7 | Chronic duodenal ulcer without hemorrhage or perforation |
| K26.9 | Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
| 0-9 | A-Z |
|---|---|
| K26 | Duodenal ulcer |
| K26.0 | Acute duodenal ulcer with hemorrhage |
| K26.1 | Acute duodenal ulcer with perforation |
| K26.2 | Acute duodenal ulcer with both hemorrhage and perforation |
| K26.3 | Acute duodenal ulcer without hemorrhage or perforation |
| K26.4 | Chronic or unspecified duodenal ulcer with hemorrhage |
| K26.5 | Chronic or unspecified duodenal ulcer with perforation |
| K26.6 | Chronic or unspecified duodenal ulcer with both hemorrhage and perforation |
| K26.7 | Chronic duodenal ulcer without hemorrhage or perforation |
| K26.9 | Duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation |
Formulary Reference Tool